]>
IRCT2013120214333N13 IRCT 2013-12-24 Barekat Pharmaceutical Company A Pilot study of anti-diabetic effects of rich Oligosaccharides fraction which is taken from Rosa arvensis in patients with type 2 diabetes comparsion of the Effects of an anti-diabetic oligosaccharide rich fraction extracted from Rosa arvensis with common treatment on diabetic patients type2( a pilot study) 2013-09-23 anticipated 40 Complete https://irct.ir/trial/13949 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A diabetes of type2. Intervention 1: The intervention group receive three capsules daily, each containing 350 mg of rich Oligosaccharides fraction taken from Rosa arvensis which is added to the standard treatment and in case of decreasing blood sugar and improvement, other drugs are gradually discontinued and after three months of normal blood glucose, rich Oligosaccharides fraction dose is gradually reduced to three days a week, 700 mg daily. Intervention 2: Control group receive treatment with a common protocol.
public
scientific Dr. Gholamreza Bahrami
Medical Biology Research Center,Prastar Boulevard,Sorkhleje
Kermanshah Iran (Islamic Republic of) +98 83 1427 6471 gbahrami@kums.ac.ir Kermanshah University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: diabetes diagnosis with fasting blood sugar over 125, or postprandial glucose over 200 or glycosylated hemoglobin level greater than 6; patient willingness and signed informed consent, age less than 65 years; history of diabetes less than 10 years; diabetes onset at least three months before. Exclusion criteria: requiring insulin injections or diagnosis of type 1 diabetes, kidney disease, liver disease, cancer, anemia and heart failure, pregnancy, glycosylated hemoglobin over 10, corticosteroids use. 1 year 65 years Both E11 Non-insulin dependent diabetes mellitus Treatment - Drugs Treatment - Drugs The intervention group receive three capsules daily, each containing 350 mg of rich Oligosaccharides fraction taken from Rosa arvensis which is added to the standard treatment and in case of decreasing blood sugar and improvement, other drugs are gradually discontinued and after three months of normal blood glucose, rich Oligosaccharides fraction dose is gradually reduced to three days a week, 700 mg daily Control group receive treatment with a common protocol. Blood sugar (FBS). Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test. Glucose tolerance test (BS). Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test. Hba1c rate. Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test. Barekat Pharmaceutical Company Approved 2013-09-11 Kermanshah University of Medical Sciences Building No.2, Shahid Beheshti, Vice Chancellor for Research Affairs, Kermanshah University of Medical SciencesBuilding No.2, Shahid Beheshti, Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences Kermanshah Iran (Islamic Republic of)